Last reviewed · How we verify
NCT03449849
Effect of Kale Consumption on Human Xenobiotic Metabolizing Enzymes
NA trial testing Base Diet in Healthy Volunteers in 27 participants. Completed in 1 August 2018.
1 August 2018
Quick facts
| Lead sponsor | USDA Beltsville Human Nutrition Research Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 18 April 2018 |
| Primary completion | 1 August 2018 |
| Estimated completion | 1 August 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Base Diet
- Kale Treatment
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
USDA Beltsville Human Nutrition Research Center
Who can join
Adults 21 to 75, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to determine how daily consumption of kale changes the activity of human xenobiotic metabolizing enzymes. Secondary objectives are to measure absorption and metabolism of kale phytonutrients, and to determine how kale consumption affects gene expression related to metabolism and lipid measures associated with cardiovascular health.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Systematic Review on the Metabolic Interest of Glucosinolates and Their Bioactive Derivatives for Human Health.
Costa-Pérez A, Núñez-Gómez V, Baenas N, Di Pede G, et al · · 2023 · cited 19× · PMID 36986155 · DOI 10.3390/nu15061424
Verify or expand the search:
- PubMed search for NCT03449849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other USDA Beltsville Human Nutrition Research Center trials
Trials by the same sponsor.
- NCT07146958 — Soup and Bread Recipe Impacts on Ingestive Behavior · NA · recruiting
- NCT06771765 — Soup Meal Satiety Study · NA · completed
- NCT05589389 — Meat and Dietary Pattern Study · NA · active not recruiting
- NCT03779971 — Energy Value of Lentils and Chickpeas · NA · completed
- NCT04104581 — Measuring Daily Grain Intake Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03449849 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by USDA Beltsville Human Nutrition Research Center
- Last refreshed: 12 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03449849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing